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Summary
Nanotechnology encompasses those technologies to fabricate materials, including sphere, 
cubic  and  needle-like  nanoscaled  particles  (approximately  5  to  100nm),  and  near-
nanoscaled devices (up to 500 nm). In comparison mycoplasma are approximately 200 
nm  in  length  and  a  nanometre  is  10-9 of  a  metre.  The  field  of  nanotechnology  is 
experiencing rapid growth, with many & diverse potential applications being explored in 
the biomedical field, including the control of infectious diseases. Nanotechnology has the 
potential to offer not only improvements to current approaches for immunisation, drug 
design  and  delivery,  diagnostics  and  cross  infection  control,  but  is  unexpectedly 
delivering many new tools and capabilities. (102 words)
 
Immunisation
The  potential  of  nanoparticles  as  novel  adjuvants  and  the  use  of  nanoemulsions  as 
colloidal  vaccine  carriers  are  being  explored  in  the  field  of  immunisation  against 
infectious diseases. Calcium nanoparticles have been examined as a vaccine adjuvant of 
anti-idiotypic antibody against schistosomiasis (Fang et al, 2004). Nanoemulsions, which 
consist  of minute droplets  of oil  suspended in water and stabilized by detergents,  are 
finding applications for both prevention and treatment of a wide variety of infections. 
Droplets  in  nanoemulsions  are  surface  active  and  react  specifically  with  the  outer 
membrane of infectious organisms. In pre-clinical trials with animals at the University of 
Michigan mixtures  of the nanoemulsion with either whole virus or protein have been 
tested as potential vaccines. Such vaccines, which do not require cold storage and can be 
administered  via  the  mucosal  route,  are  particularly  suitable  for  applications  in 
developing countries.
Cross Infection Control
Exploitation  of  the  toxic  properties  of  nanoparticulate  metals  and metal  oxides,  in 
particular  those  that  produce  reactive  oxygen  species  under  UV  light,  are  finding 
increasing use in antimicrobial formulations and dressings within and outside the hospital 
environment. Silver, copper and their compounds have been widely used. In particular, 
nano silver particles (5-40 nm) have been reported to inactivate most microorganisms, 
including  HIV-1.  The  high  reactivity  of  titanium dioxide  and silicon  dioxide  is  also 
exploited extensively for their bactericidal purposes in filters and coatings on substrates 
such  as  alumina  (Han  et  al 2005).  Significant  activity  using  the  latest  generation  of 
nanoparticles, and their compound clusters, against fungal and bacterial pathogens, such 
as Methicillin resistant Staphylococcus aureus (MRSA) and Escherichia coli has recently 
been demonstrated at Queen Mary. Research carried out by Retroscreen Virology, Queen 
Mary and QinetiQ Nanomaterials  has also shown the capability  to  inactivate  viruses, 
including  SARS,  bird  flu,  and  HIV.  For  example,  specially  developed  nanoparticle 
clusters can reduce virus levels by 80-100% through direct contact.
Detection
Nanotechnology is finding uses in the rapid diagnosis of infectious diseases, whereby the 
increased functional surface area per unit volume can be exploited for use in diagnostics. 
Biosensors, devices in which a biological sensing element is either intimately connected 
to  or  integrated  within  a  transducer,  are  being  developed.  Nano-fabricated  structures, 
coated with elements such as gold that have affinity for biomolecules, are incorporated 
into these biosensors.  For  example,  a rapid  method for the  detection  of urinary tract 
infection, caused by Escherichia coli, has been developed with the application of such a 
nanotechnology approach (Basu  et al, 2004). The detection system, partly based upon 
enzyme-linked  immunosorbant  assay  technology,  utilises  anti-E.  coli antibody-bound 
Gold Nanowire Arrays (GNWA) on an anodized porous alumina template.  It has also 
been  shown  possible  to  detect  minute  amounts  of  target  DNA  strands  with 
complementary  DNA linked  to  gold  nanoparticles  (Cao  et  al,  2002).  This  particular 
approach is also finding applications in the detection of single-nucleotide polymorphisms 
(SNPs) in microarray-based systems. It has even been possible to distinguish antibiotic 
resistant bacteria, such as Staphylococcus aureus, from non-resistant strains. Biosensors 
and nucleic acid detection methods are also finding applications for the rapid detection of 
biological warfare agents. 
Treatment
The fundamental properties and bioactivity of drugs and other materials can be changed 
at the nanometre level. In theory it should be possible to control the characteristics of 
drugs  including  solubility,  controlled  release  and  specific  site-targeted  delivery.  A 
nanotechnological  approach to formulate  suitable  colloidal  carriers  for the delivery of 
drugs and genes is currently under investigation by many laboratories. Chitosan-coated 
nanocapsules  as triclosan carriers  have been found to be particularly effective in this 
capacity. This approach may be of use in the delivery of triclosan as an effective anti-
malarial  drug  by  inhibiting  the  growth  of  Plasmodium  falciparum (Maestrelli  et  al, 
2004).Chitosan can also effectively bind DNA and protect it from nuclease degradation 
in  vivo.  The  application  of  DNA-chitosan  nanospheres  for  gene  delivery  is  currently 
under investigation.
Safety Issues
In  theory  certain  nanoparticles  may  be  retained  within  the  body  for  longer  than  is 
desirable,  thus  the  safety  profile  becomes  a  matter  of  overriding  significance. 
Nanomaterials are able to cross biological membranes and gain access to cells, tissues 
and organs that larger-sized particles normally cannot. Nanomaterials can gain access to 
the  blood  stream  following  inhalation  or  ingestion.  Some  nanomaterials  can  even 
penetrate  the  skin.  Recent  studies  have  found that  a  particle’s  surface  chemistry  can 
govern  whether  it  will  be  suitable  for  biomedical  applications.  It  remains  to  be 
determined how potential toxicity issues will impact on the use of nanotechnology in the 
control of infectious diseases. (861 words – total)
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